{
  "DOI": "10.1038/s41431-021-00964-0",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-021-00964-0",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eUnsolicited findings (UFs) are uncovered unintentionally and predispose to a disease unrelated to the clinical question. The frequency and nature of UFs uncovered in clinical practice remain largely unexplored. We here evaluated UFs identified during a 5-year period in which 16,482 index patients received clinical whole-exome sequencing (WES). UFs were identified in 0.58% (95/16,482) of index patients, indicating that the overall frequency of UFs in clinical WES is low. Fewer UFs were identified using restricted disease-gene panels (0.03%) than when using whole-exome/Mendeliome analysis (1.03%). The UF was disclosed to 86 of 95 individuals, for reasons of medical actionability. Only 61% of these UFs reside in a gene that is listed on the “ACMG59”-list, representing a list of 59 genes for which the American College of Medical Genetics recommends UF disclosure. The remaining 39% were grouped into four categories: disorders similar to “ACMG59”-listed disorders (25%); disorders for which disease manifestation could be influenced (7%); UFs providing reproductive options (2%); and UFs with pharmacogenetic implications (5%). Hence, our experience shows that UFs predisposing to medically actionable disorders affect a broader range of genes than listed on the “ACMG59”, advocating that a pre-defined gene list is too restrictive, and that UFs may require ad hoc evaluation of medical actionability. While both the identification and disclosure of UFs depend on local policy, our lessons learned provide general essential insight into the nature and odds of UFs in clinical exome sequencing.\u003c/jats:p\u003e",
  "alternative-id": [
    "964"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "11 April 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "2 August 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "9 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "25 October 2021"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "All data presented in this study are anonymized, following data obtained through routine diagnostic procedures including consent (IRB approval 2011-188)."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "van der Schoot",
      "given": "Vyne",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Haer-Wigman",
      "given": "Lonneke",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Feenstra",
      "given": "Ilse",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tammer",
      "given": "Femke",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-1791-1620",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Oerlemans",
      "given": "Anke J. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Koolwijk",
      "given": "Martine P. A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Agt",
      "given": "Frans",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Arens",
      "given": "Yvonne H. J. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Brunner",
      "given": "Han G.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-6470-5497",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Vissers",
      "given": "Lisenka E. L. M.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3877-6328",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Yntema",
      "given": "Helger G.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        10,
        25
      ]
    ],
    "date-time": "2021-10-25T08:03:24Z",
    "timestamp": 1635149004000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        2,
        8
      ]
    ],
    "date-time": "2022-02-08T00:03:45Z",
    "timestamp": 1644278625000
  },
  "funder": [
    {
      "DOI": "10.13039/100010661",
      "award": [
        "779257",
        "779257"
      ],
      "doi-asserted-by": "publisher",
      "name": "EC | Horizon 2020 Framework Programme"
    },
    {
      "DOI": "10.13039/501100001826",
      "award": [
        "015014066",
        "843002608"
      ],
      "doi-asserted-by": "publisher",
      "name": "ZonMw"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        17
      ]
    ],
    "date-time": "2024-04-17T21:15:30Z",
    "timestamp": 1713388530560
  },
  "is-referenced-by-count": 15,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2021,
        10,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2022,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            25
          ]
        ],
        "date-time": "2021-10-25T00:00:00Z",
        "timestamp": 1635120000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            25
          ]
        ],
        "date-time": "2021-10-25T00:00:00Z",
        "timestamp": 1635120000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-021-00964-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00964-0",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00964-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "170-177",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2021,
        10,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        10,
        25
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1097/GIM.0b013e318220aaba",
      "author": "JS Berg",
      "doi-asserted-by": "publisher",
      "first-page": "499",
      "journal-title": "Genet Med",
      "key": "964_CR1",
      "unstructured": "Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med. 2011;13:499–504.",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1038/gim.2016.190",
      "author": "SS Kalia",
      "doi-asserted-by": "publisher",
      "first-page": "249",
      "journal-title": "Genet Med",
      "key": "964_CR2",
      "unstructured": "Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19:249–55.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2012.157",
      "author": "TA Manolio",
      "doi-asserted-by": "publisher",
      "first-page": "258",
      "journal-title": "Genet Med",
      "key": "964_CR3",
      "unstructured": "Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15:258–67.",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ejhg.2011.258",
      "author": "C Gilissen",
      "doi-asserted-by": "publisher",
      "first-page": "490",
      "journal-title": "Eur J Hum Genet",
      "key": "964_CR4",
      "unstructured": "Gilissen C, Hoischen A, Brunner HG, Veltman JA. Disease gene identification strategies for exome sequencing. Eur J Hum Genet. 2012;20:490–7.",
      "volume": "20",
      "year": "2012"
    },
    {
      "DOI": "10.1038/s41431-017-0043-9",
      "author": "DF Vears",
      "doi-asserted-by": "publisher",
      "first-page": "36",
      "journal-title": "Eur J Hum Genet",
      "key": "964_CR5",
      "unstructured": "Vears DF, Senecal K, Clarke AJ, Jackson L, Laberge AM, Lovrecic L, et al. Points to consider for laboratories reporting results from diagnostic genomic sequencing. Eur J Hum Genet. 2018;26:36–43.",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1101/gr.183483.114",
      "author": "LM Amendola",
      "doi-asserted-by": "publisher",
      "first-page": "305",
      "journal-title": "Genome Res",
      "key": "964_CR6",
      "unstructured": "Amendola LM, Dorschner MO, Robertson PD, Salama JS, Hart R, Shirts BH, et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015;25:305–15.",
      "volume": "25",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ajhg.2013.08.006",
      "author": "MO Dorschner",
      "doi-asserted-by": "publisher",
      "first-page": "631",
      "journal-title": "Am J Hum Genet",
      "key": "964_CR7",
      "unstructured": "Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ, et al. Actionable, pathogenic incidental findings in 1000 participants’ exomes. Am J Hum Genet. 2013;93:631–40.",
      "volume": "93",
      "year": "2013"
    },
    {
      "DOI": "10.1001/jama.2014.14601",
      "author": "Y Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1870",
      "journal-title": "JAMA.",
      "key": "964_CR8",
      "unstructured": "Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312:1870–9.",
      "volume": "312",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s00439-017-1852-1",
      "author": "CS Tang",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Hum Genet",
      "key": "964_CR9",
      "unstructured": "Tang CS, Dattani S, So MT, Cherny SS, Tam PKH, Sham PC, et al. Actionable secondary findings from whole-genome sequencing of 954 East Asians. Hum Genet. 2018;137:31–7.",
      "volume": "137",
      "year": "2018"
    },
    {
      "DOI": "10.1371/journal.pone.0135193",
      "author": "E Olfson",
      "doi-asserted-by": "publisher",
      "first-page": "e0135193",
      "journal-title": "Plos One",
      "key": "964_CR10",
      "unstructured": "Olfson E, Cottrell CE, Davidson NO, Gurnett CA, Heusel JW, Stitziel NO, et al. Identification of medically actionable secondary findings in the 1000 genomes. Plos One. 2015;10:e0135193.",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.aaf6814",
      "author": "FE Dewey",
      "doi-asserted-by": "publisher",
      "first-page": "6319",
      "journal-title": "Science",
      "key": "964_CR11",
      "unstructured": "Dewey FE, Murray MF, Overton JD, Habegger L, Leader JB, Fetterolf SN, et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science 2016;354:6319.",
      "volume": "354",
      "year": "2016"
    },
    {
      "DOI": "10.1126/scitranslmed.aag2367",
      "author": "P Natarajan",
      "doi-asserted-by": "publisher",
      "first-page": "364",
      "journal-title": "Sci Transl Med",
      "key": "964_CR12",
      "unstructured": "Natarajan P, Gold NB, Bick AG, McLaughlin H, Kraft P, Rehm HL, et al. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans. Sci Transl Med. 2016;8:364–151.",
      "volume": "8",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ebiom.2016.01.030",
      "author": "SS Jamuar",
      "doi-asserted-by": "publisher",
      "first-page": "211",
      "journal-title": "eBioMedicine",
      "key": "964_CR13",
      "unstructured": "Jamuar SS, Kuan JL, Brett M, Tiang Z, Tan WL, Lim JY, et al. Incidentalome from genomic sequencing: a barrier to personalized medicine? eBioMedicine 2016;5:211–6.",
      "volume": "5",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2014.29",
      "author": "L Lawrence",
      "doi-asserted-by": "publisher",
      "first-page": "741",
      "journal-title": "Genet Med",
      "key": "964_CR14",
      "unstructured": "Lawrence L, Sincan M, Markello T, Adams DR, Gill F, Godfrey R, et al. The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience. Genet Med. 2014;16:741–50.",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41436-018-0308-x",
      "author": "MR Hart",
      "doi-asserted-by": "publisher",
      "first-page": "1100",
      "journal-title": "Genet Med",
      "key": "964_CR15",
      "unstructured": "Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, et al. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med. 2019;21:1100–10.",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1038/gim.2018.53",
      "author": "ML Thompson",
      "doi-asserted-by": "publisher",
      "first-page": "1635",
      "journal-title": "Genet Med",
      "key": "964_CR16",
      "unstructured": "Thompson ML, Finnila CR, Bowling KM, Brothers KB, Neu MB, Amaral MD, et al. Genomic sequencing identifies secondary findings in a cohort of parent study participants. Genet Med. 2018;20:1635–43.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1038/ejhg.2017.9",
      "author": "L Haer-Wigman",
      "doi-asserted-by": "publisher",
      "first-page": "591",
      "journal-title": "Eur J Hum Genet",
      "key": "964_CR17",
      "unstructured": "Haer-Wigman L, van Zelst-Stams WA, Pfundt R, van den Born LI, Klaver CC, Verheij JB, et al. Diagnostic exome sequencing in 266 Dutch patients with visual impairment. Eur J Hum Genet. 2017;25:591–9.",
      "volume": "25",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2016.163",
      "author": "R Pfundt",
      "doi-asserted-by": "publisher",
      "first-page": "667",
      "journal-title": "Genet Med",
      "key": "964_CR18",
      "unstructured": "Pfundt R, Del Rosario M, Vissers L, Kwint MP, Janssen IM, de Leeuw N, et al. Detection of clinically relevant copy-number variants by exome sequencing in a large cohort of genetic disorders. Genet Med. 2017;19:667–75.",
      "volume": "19",
      "year": "2017"
    },
    {
      "key": "964_CR19",
      "unstructured": "Bell J, Bodmer D, Sistermans E, Ramsden S. Practice guidelines for the interpretation and reporting of unclassified variants (UVs) in clinical molecular genetics. Clin Mol Genet Soc. 2006."
    },
    {
      "key": "964_CR20",
      "unstructured": "Wallis Y, Payne S, McAnulty C, Bodmer D, Sistermans E, Robertson K, et al. Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics: ACGS/VGKL; 2013."
    },
    {
      "DOI": "10.1038/s41431-018-0244-x",
      "author": "M Silva",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Eur J Hum Genet",
      "key": "964_CR21",
      "unstructured": "Silva M, de Leeuw N, Mann K, Schuring-Blom H, Morgan S, Giardino D, et al. European guidelines for constitutional cytogenomic analysis. Eur J Hum Genet. 2019;27:1–16.",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med: Off J Am Coll Med Genet",
      "key": "964_CR22",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med: Off J Am Coll Med Genet. 2015;17:405–24.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ejhg.2016.63",
      "author": "G Matthijs",
      "doi-asserted-by": "publisher",
      "first-page": "1515",
      "journal-title": "Eur J Hum Genet",
      "key": "964_CR23",
      "unstructured": "Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, et al. Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet. 2016;24:1515.",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41431-018-0284-2",
      "author": "L Haer-Wigman",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "journal-title": "Eur J Hum Genet.",
      "key": "964_CR24",
      "unstructured": "Haer-Wigman L, van der Schoot V, Feenstra I, Vulto-van Silfhout AT, Gilissen C, Brunner HG. et al. 1 in 38 individuals at risk of a dominant medically actionable disease. Eur J Hum Genet.2019;27:325–30.",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1210/jc.2017-01762",
      "author": "K Van der Tuin",
      "doi-asserted-by": "publisher",
      "first-page": "438",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "964_CR25",
      "unstructured": "Van der Tuin K, Mensenkamp AR, Tops CMJ, Corssmit EPM, Dinjens WN, van de Horst-Schrivers ANA, et al. Clinical aspects of SDHA-related pheochromocytoma and paraganglioma: a nationwide study. J Clin Endocrinol Metab. 2018;103:438–45.",
      "volume": "103",
      "year": "2018"
    },
    {
      "key": "964_CR26",
      "unstructured": "Nederland VKG. Erfelijke en familiaire tumoren. Richtlijnen voor diagnostiek en preventie. CHEK2-geassocieerd Mammacarcinoom: Stichting Opsporing Erfelijke Tumoren en de Vereniging Klinische Genetica Nederland, Werkgroep Klinische Oncogenetica; 2017. 3."
    },
    {
      "DOI": "10.1016/j.ajhg.2021.03.004",
      "author": "H Fridman",
      "doi-asserted-by": "publisher",
      "first-page": "608",
      "journal-title": "Am J Hum Genet",
      "key": "964_CR27",
      "unstructured": "Fridman H, Yntema HG, Mägi R, Andreson R, Metspalu A, Mezzavila M, et al. The landscape of autosomal-recessive pathogenic variants in European populations reveals phenotype-specific effects. Am J Hum Genet. 2021;108:608–19.",
      "volume": "108",
      "year": "2021"
    },
    {
      "DOI": "10.3390/genes10060416",
      "author": "CH van der Wouden",
      "doi-asserted-by": "crossref",
      "first-page": "6",
      "journal-title": "Genes",
      "key": "964_CR28",
      "unstructured": "van der Wouden CH, Bank PCD, Ozokcu K, Swen JJ, Guchelaar HJ. Pharmacist-initiated pre-emptive pharmacogenetic panel testing with clinical decision support in primary care: record of PGx results and real-world impact. Genes. 2019;10:6.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1038/gim.2017.157",
      "author": "E Ormondroyd",
      "doi-asserted-by": "publisher",
      "first-page": "320",
      "journal-title": "Genet Med",
      "key": "964_CR29",
      "unstructured": "Ormondroyd E, Mackley MP, Blair E, Craft J, Knight JC, Taylor JC, et al. “Not pathogenic until proven otherwise”: perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project. Genet Med. 2018;20:320–8.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2017.269",
      "author": "KE Weck",
      "doi-asserted-by": "publisher",
      "first-page": "291",
      "journal-title": "Genet Med",
      "key": "964_CR30",
      "unstructured": "Weck KE. Interpretation of genomic sequencing: variants should be considered uncertain until proven guilty. Genet Med. 2018;20:291–3.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41431-019-0438-x",
      "author": "B Isidor",
      "doi-asserted-by": "publisher",
      "first-page": "1481",
      "journal-title": "Eur J Hum Genet",
      "key": "964_CR31",
      "unstructured": "Isidor B, Julia S, Saugier-Veber P, Weil-Dubuc PL, Bezieau S, Bieth E, et al. Searching for secondary findings: considering actionability and preserving the right not to know. Eur J Hum Genet. 2019;27:1481–4.",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41431-021-00834-9",
      "author": "V Van der Schoot",
      "doi-asserted-by": "publisher",
      "first-page": "930",
      "journal-title": "Eur J Hum Genet",
      "key": "964_CR32",
      "unstructured": "Van der Schoot V, Viellevoije SJ, Tammer F, Brunner HG, Arens Y, Yntema HG, et al. The impact of unsolicited findings in clinical exome sequencing, a qualitative interview study. Eur J Hum Genet. 2021;29:930–9.",
      "volume": "29",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s10897-018-0289-6",
      "author": "MC Gornick",
      "doi-asserted-by": "publisher",
      "first-page": "334",
      "journal-title": "J Genet Couns",
      "key": "964_CR33",
      "unstructured": "Gornick MC, Ryan KA, Scherer AM, Scott Roberts J, De Vries RG, Uhlmann WR. Interpretations of the term “actionable” when discussing genetic test results: what you mean is not what i heard. J Genet Couns. 2019;28:334–42.",
      "volume": "28",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s40142-015-0075-9",
      "author": "MI Roche",
      "doi-asserted-by": "publisher",
      "first-page": "166",
      "journal-title": "Curr Genet Med Rep",
      "key": "964_CR34",
      "unstructured": "Roche MI, Berg JS. Incidental findings with genomic testing: implications for genetic counseling practice. Curr Genet Med Rep. 2015;3:166–76.",
      "volume": "3",
      "year": "2015"
    },
    {
      "key": "964_CR35",
      "unstructured": "Hernandez JBR, Kim PY. Epidemiology morbidity and mortality. StatPearls. Treasure Island (FL) 2020."
    }
  ],
  "reference-count": 35,
  "references-count": 35,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-021-00964-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Lessons learned from unsolicited findings in clinical exome sequencing of 16,482 individuals"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "30"
}